C. difficile

Roche's new tests to detect Clostridium difficile and genital herpes infection have been cleared by the FDA.

Clostridium difficile-associated diarrhea (CDAD) is an increasingly common cause of inpatient mortality, and recurrent CDAD remains clinically challenging.

The US Centers for Disease Control and Prevention today reported that nearly half a million Clostridium difficile infections occurred in a single year, highlighting a critical need for improved antibiotic use.